Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{169880,
        author = {Falguni Pradip Sapkal},
        title = {mRNA vaccines : present scenario, challenges and future.},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {6},
        pages = {2476-2481},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=169880},
        abstract = {The mRNA vaccines supplement our conventional vaccines (live-attenuated and inactivated vaccines) in reality by their extremely safety, efficacy, potency, and low manufacturing cost. These many years, the administration of these mRNA vaccines was immensely limited due to their instability and low efficiency in vivo delivery. However, at present, some of the problems have been solved through recent technological advances. The positive outcomes of mRNA vaccines were proved by the conducted studies with animals and humans to show the success. This study presents you with a thorough introduction of mRNA viral vaccines and assesses the current points of view and future advancements.},
        keywords = {mRNA vaccines , lipid nanoparticles, virus , cancer .},
        month = {November},
        }